Longevity startup offers AI-powered blood biomar
Author: Michael
New research finds that endothelial TDP-43 loss
Progress in spinal cord injury lays the foundati
London is the setting for the next edition of a
Immorta Bio is developing autologous stem cell a
New COO Michael Ringel says company is confident
Company gears up for pivotal trials of AI-develo
New research highlights the dominant role of env
Company’s platform integrates labs and more th
Regenerative medicine startup aims to regenerate